Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system.

ABSTRACT: A key challenge in the field of therapeutic viral vector/vaccine manufacturing is maximizing production. For most vector platforms, the 'benchmark' vector titres are achieved with inert reporter genes. However, expression of therapeutic transgenes can often adversely affect vector titres due to biological effects on cell metabolism and/or on the vector virion itself. Here, we exemplify the novel 'Transgene Repression In vector Production' (TRiP) system for the production of both RNA- and DNA-based viral vectors. The TRiP system utilizes a translational block of one or more transgenes by employing the bacterial tryptophan RNA-binding attenuation protein (TRAP), which binds its target RNA sequence close to the transgene initiation codon. We report enhancement of titres of lentiviral vectors

SUBMITTER: Maunder HE 

PROVIDER: S-EPMC5378976 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature